Fishawack Health adds FIDE to the group

Global healthcare professionals for FIDE give biopharmaceutical companies a look into initial research and clinical evidence about use and benefits of the product after they have been approved. FIDE’s advisory services provide their clients with an understanding of main problems for boosting health outcomes for individuals worldwide.

Fishawack Health is dedicated to finding solutions for people dealing with long term inflammatory skin conditions, as seen by their keen support for FIDE. The focus of Biopharmaceutical companies is currently on finding possible medical treatments for these problems; there are over 80 treatments for atopic dermatitis and psoriasis being produced now. Professionals struggle to handle the sheer volume of data available to them because of a growth in research and development, which has resulted in an overcrowded market.

With the new addition of FIDE’s experts, Fishawack Health will be able to share essential information and expertise with dermatology clients so they can address stakeholders’ dynamic requirements.

Executive Director at FIDE, Bruce Strober, said “There is a fantastic opportunity for life science companies to better support dermatologists in navigating the innovations launching in the next few years. By joining Fishawack Health, we can connect our knowledge of the field with Fishawack Health’s deep expertise in services supporting clients through the product lifecycle to help life science companies transform patients’ lives.”

Gail Flockhart, Group President, said “FIDE is a compelling addition to our group. The company’s expert-led approach provides our clients with insights into a highly innovative and complex market with significant unmet patient needs. We have worked with FIDE for more than a decade, and our partnership has been tremendously successful in supporting clients with access to expert insight. We are delighted to continue to deliver this work and to develop the service offering further now they are fully part of the group.”

Fishawack Health CEO, Jonathan Koch, said “I’m incredibly excited to welcome such a talented team to our organization. FIDE’s key opinion leaders will add a unique lens to our services for our dermatology clients—one that I have not seen before in the agency and consulting worlds. When combined with our team’s expertise across the product life cycle, we can solve an array of complex challenges for our clients, empowering them with novel solutions that truly get to the heart of healthcare professionals’ and patients’ challenges.”